BidaskClub upgraded shares of Express Scripts (NASDAQ:ESRX) from a buy rating to a strong-buy rating in a research report sent to investors on Friday morning.
ESRX has been the topic of a number of other research reports. ValuEngine upgraded Express Scripts from a hold rating to a buy rating in a research report on Monday, September 17th. Credit Suisse Group downgraded Express Scripts from an outperform rating to a neutral rating and lifted their target price for the company from $90.00 to $96.50 in a research report on Tuesday, September 18th. Zacks Investment Research downgraded Express Scripts from a hold rating to a sell rating in a research report on Monday, July 23rd. William Blair upgraded Express Scripts from a market perform rating to an outperform rating in a research report on Wednesday, August 1st. Finally, Royal Bank of Canada lifted their target price on Express Scripts to $94.00 and gave the company an outperform rating in a research report on Monday, August 27th. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $86.36.
NASDAQ:ESRX traded up $0.55 on Friday, reaching $94.29. The company’s stock had a trading volume of 2,922,063 shares, compared to its average volume of 4,316,647. Express Scripts has a 12-month low of $55.80 and a 12-month high of $97.22. The company has a quick ratio of 0.59, a current ratio of 0.71 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $53.41 billion, a P/E ratio of 13.28, a P/E/G ratio of 1.20 and a beta of 1.01.
In related news, insider Christine Houston sold 12,898 shares of the business’s stock in a transaction on Friday, August 10th. The stock was sold at an average price of $85.00, for a total value of $1,096,330.00. Following the sale, the insider now owns 110,908 shares in the company, valued at approximately $9,427,180. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.79% of the stock is currently owned by insiders.
Several hedge funds have recently bought and sold shares of ESRX. Landaas & Co. WI ADV purchased a new stake in shares of Express Scripts in the 2nd quarter valued at about $102,000. Kaizen Advisory LLC lifted its holdings in shares of Express Scripts by 147.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock valued at $104,000 after purchasing an additional 800 shares during the last quarter. Adviser Investments LLC lifted its holdings in shares of Express Scripts by 321.9% in the 2nd quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock valued at $114,000 after purchasing an additional 1,130 shares during the last quarter. Sun Life Financial INC lifted its holdings in shares of Express Scripts by 758.8% in the 2nd quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock valued at $117,000 after purchasing an additional 1,343 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its holdings in shares of Express Scripts by 3,048.1% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,637 shares of the company’s stock valued at $126,000 after purchasing an additional 1,585 shares during the last quarter. Hedge funds and other institutional investors own 84.73% of the company’s stock.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Story: Exchange-Traded Funds (ETFs)
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.